/L) and elevated C-reactive protein. No clear infective cause was found despite numerous investigations, including blood, bone marrow, urine and stool cultures. Bone marrow biopsy revealed an agranulocytosis with an apparent maturation block at the myeloblasts stage but no features of haemophagocytosis and Epstein-Barr virus (EBV) in situ hybridization was negative. Neutrophil recovery occurred following daclizumab cessation and the initiation of T cell immunosuppressive therapy with systemic corticosteroids and methotrexate.
Results: A novel heterozygous missense variant in CTLA4 (c.410C>T; p. Pro137Leu in exon 2 of CTLA4) was identified in our patient, leading to a diagnosis of CHAI. This novel variant affects the CTLA-4 protein at a highly conserved amino acid in an essential functional domain and is classified as 'likely pathogenic'. The proband's brother and mother were also confirmed to carry the mutation.
Conclusion:
This case shows that autoimmune disease may be the presenting feature of primary immunodeficiency and should be appropriately investigated prior to the commencement of immunotherapy. Genetic clarification of underlying primary immunodeficiency may provide critical clinical information that alters the safety of the proposed treatment strategy. Aim: To identify DRESS cases, including demographics, culprit drugs, management and clinical outcomes in a large tertiary hospital in Western Australia.
P56 DRESS SYNDROME: A WEST AUSTRALIAN TERTIARY HOSPITAL EXPERIENCE
Methods: Inpatients between January 2009 and March 2018 were identified using coding for drug fever, rash and eosinophilia. Outpatients were identified through immunology clinic letters. Cases were confirmed using the RegiSCAR) criteria.
Results: Of the 473 inpatients, 66 were duplicates and 31 had a DRESS diagnosis. Eleven outpatients were identified. Of the 42 patients, 12 were excluded. There were 8, 10, and 13 cases in the 2010-2012, 2013-2015 and 2016-2018 periods respectively.
The average age was 57 years with 18 male and 13 females. Specialties at diagnosis included general medicine (n=11) and surgical teams (n=6). The culprit drugs included antibiotic(s) (n=17), and anticonvulsants (n=6).
Drug administration to time of diagnosis was on average 24.4 days with an average peak eosinophilia of 4.02x10 9 /L. Associated organs included liver (n=13), kidney (n=14) and heart (n=2). Management included prednisolone (n=18) and supportive care/change of agent or prompt cessation of the culprit drug (n=8). Twenty five cases resolved, three had ongoing symptoms, two progressed to TEN with 1 death, and another death from pneumonia.
Discussion and Conclusion:
This retrospective study highlights an increasing prevalence of DRESS, especially over the last three years. It suggests antibiotics as the major culprit drugs with liver and kidney as major solid organs affected. Corticosteroids remain the mainstay of treatment. As majority of the cases were reported in general medical and surgical teams, education and prompt identification is warranted for optimal management and prevention of complications. Background: Hereditary angioedema (HAE), a rare genetic disorder, results from an inherited deficiency or dysfunction of C1-inhibitor (C1-INH). Recurrent episodes of angioedema are associated with considerable morbidity and quality-of-life (QoL) impact. Long-term prophylaxis (LTP) to reduce breakthrough attack frequency and severity can ameliorate this burden. There are differences in opinion about the appropriate LTP initiation criteria and regimen. This study describes international physician perspectives on these issues via a literature review.
P57 PHYSICIAN PERSPECTIVES ON LONG-TERM PROPHYLAXIS OF
Methods: A targeted search of peer-reviewed studies published from 2002-2018 was conducted. Inclusion criteria were publications discussing the physician perspective on the appropriate LTP criteria and/or regimen. Exclusion criteria were documents other than comments, consensuses, guidelines, letters, reviews, and editorials; and, articles including only pediatric patients. References were reviewed and evaluated for inclusion.
Results: 493 articles were identified in the search; 53 relevant articles were included in the review. 28% of inclusions were guidelines; 25% were expert consensuses. 47% provided an international perspective; the remainder were country-specific. 72% were published post-2011: these were more likely to define an individualized patient care approach and a broader set of criteria when determining suitability of LTP including attack frequency, severity, impact on QoL, failure of on-demand treatment and access to healthcare services; less likely to cite number attacks as a primary LTP criterion; and more likely to recommend C1-INH for LTP.
Conclusion: Physicians' perspectives on LTP have changed over time. Recent guidelines no longer provide the number of HAE attack days as the sole criteria for LTP initiation. Guidelines recommend a broader set of criteria and an individualized patient care approach when determining suitability of LTP. 
